Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient.
With the broad employment of immunosuppressive therapy, the incidence of Pseudallescheria boydii infections is rising. We report a first case of the localized subcutaneous P. boydii infection in a patient with microscopic polyangiitis. Favorable outcome related to the treatment with voriconazole adds to the growing body of evidence supporting the use of this particular agent in P. boydii infections.
Department of Internal Medicine, General Hospital Murska Sobota, 9000, Murska Sobota, Slovenia. mitja.lainscak@guest.arnes.si
Mitja
M
Lainscak
Alojzija
A
Hocevar
Dusan
D
Logar
Bojana
B
Beović
Tadeja
T
Matos
Matija
M
Tomsic
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects*; D008875:Middle Aged; D008271:Mycetoma / Q000276:immunology*; D011541:Pseudallescheria / Q000276:immunology* / Q000472:pathogenicity; D014657:Vasculitis / Q000188:drug therapy / Q000382:microbiology
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone